Slide 1: 1H FY24 Results
1H FY24 Results 30 August 2024
Slide 2: Agenda
Agenda 1H FY24 Results 1. Overview 2. Results Highlights 3. Financials 4. Strategy & Outlook 2
Slide 3: Overview
imexHSs Overview
Slide 4: One Company with two businesses aimed at democratising access to medical imaging expertise
One Company with two businesses aimed at democratising access to medical imaging expertise Medical Imaging Software Radiology Services Provider of innovative, cloud-based, Outsourcing of imaging facilities AI medical imaging software and teleradiology to hospitals and solutions medical facilities 4
Slide 5: Global footprint
Global footprint Software 19 countries; 518 sites 3,326 radiologists 27 distributors in 16 countries Radiology Colombia, Spain and Mexico 36 radiology centres 160+ in-house radiologists 5
Slide 6: 1H FY24 Results Highlights
imexHs 1H FY24 Results Highlights
Slide 7: Business Highlights
Business Highlights • The Company has demonstrated the scalability of the business across different geographies with an attractive product and disruptive business model and now is focused on generating positive earnings and cashflow. • Focus is on sales within Latin America and those product develop
Slide 8: 1H FY24 Operational Highlights
1H FY24 Operational Highlights • Enterprise software contract renewal with • Software development program of Enterprise Colsubsidio with improved terms and pricing. New Value Proposition remains on time and on The 3-year software contract is expected to budget with trials of the early-stage product
Slide 9: 1H FY24 Financial Highlights
1H FY24 Financial Highlights Sales Revenue Annual Recurring Underlying Revenue (ARR) 2 EBITDA3 Up 57% yoy $13.8m Up 21% yoy $29.6m vs $0.5m in pcp $0.3m Up 32% on a constant Up 21% on a constant currency basis1 currency basis Recurring Closing cash Debt revenue 95% of total revenue $13.1m vs $2.4m a
Slide 10: 1H FY24 Business Unit Results
1H FY24 Business Unit Results $M Software Radiology Corporate Total Revenue 4.9 8.9 - 13.8 Underlying 2.6 (0.2) (2.1) 0.3 EBITDA ARR 9.9 19.7 - 29.6 • Software primarily relates to sales of IMEXHS Enterprise and growing IMEXHS Cloud business ➢ Revenue up 40% vs pcp ➢ ARR up 9% from $9.1m revised* at
Slide 11: 1H FY24 Financials
imexHs 1H FY24 Financials
Slide 12: Progress in ARR
Progress in ARR ARR as at 30 June 2024 • $29.6m, up 25% vs 31 Dec-23: ➢ Software - $9.9m, up 9% vs $9.1m at 31 Dec-23; and ➢ Radiology services - $19.7m, up 36% vs $14.5m at 31 Dec-23. (1) Constant currency basis assumes that historical results at each year end are converted at the 30 Jun-24 exchang
Slide 13: Income Statement
Income Statement #039;000 1H FY24 1H FY23 Var Var % • Revenue of $13.8m, up 57% yoy and 32% on a constant currency basis Revenue 13,785 8,804 4,981 57% • Underlying EBITDA of $0.3m down Other revenue 105 76 29 38% $0.2m versus pcp profit of $0.5m Total revenue 13,890 8,880 5,010 56% • Underlying EBITDA
Slide 14: Balance Sheet
Balance Sheet #039;000 Jun 24 Dec 23 Jun 23 • Closing cash balance of $1.9m as at 30 Jun-24 Cash 1,893 2,362 1,966 and Net Assets of $15.1m Trade & other receivables 7,863 6,443 7,467 • Intangible assets of $8.1m include Goodwill of Inventories 234 112 112 $4.5m, Software of $2.7m, $0.8m of customer Cu
Slide 15: Summary Cash Flow
Summary Cash Flow #039;000 1H FY24 1H FY23 • Closing cash balance of $1.9m as at 30-Jun-24 vs pcp of $2.0m Net cash (used in)/from operating activities (1,476) 1,410 Net cash (used in)/from investing activities 120 (1,026) • Revenue growth in the half consumed significant working capital leading to Net
Slide 16: Strategy & Outlook
imexHs Strategy & Outlook
Slide 17: New Value Proposition
New Value Proposition Radiologists with Superpowers 1 Product. “The most advanced, contemporary and secure radiology AI enhanced software solution.” Current status: - New multitenant cloud-native RIS developed. - Ready for ISO 27001 and 2 Customer Service & Support. HIPPA Certification. “Unparallele
Slide 18: Product and Software Updates
Product and Software Updates ● Radiology Information System ● Universal Viewer v6.3.2 Enhancements (cont.) ➢ Wide range of new features and ➢ New authentication service, standard for log functionalities developed for the enhanced storage, improvement on loading speed of iteration of AQUILA (the RIS-
Slide 19: Focus for FY24
Focus for FY24 Software Radiology Services 1) Rolling out New Value Proposition 1) Profit improvement efforts have led to the renegotiation of several o Enhanced digital security: Get ISO 27001 certification. contracts, resulting in better o Service levels: Create a "wow" factor. terms and pricing o
Slide 20: FY24 Outlook
FY24 Outlook Key drivers for revenue and earnings February 2024 Guidance growth: • Revenue of $24.0 – $27.0m • Annualised Recurring Revenue (22% – 37% up vs FY23) recently contracted and contracted but not yet billing. • Underlying EBITDA of $1.5 - $3.5m (up vs $0.5m in FY23) • Current pipeline of o
Slide 21: Q&A
Q&A
Slide 22: Disclaimer
Disclaimer The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipient on the terms and co
Slide 23: Disclaimer
Disclaimer Investors should be aware that certain financial measures included in this presentation are ‘non-IFRS financial information’ under ASIC Regulatory Guide 230: ‘Disclosing non-IFRS financial information’ published by ASIC and are not recognised under International Financial Reporting Standa
Slide 24: 1H FY24 Results
1H FY24 Results 30 August 2024